Literature DB >> 17982213

Consumer evaluation of a disability care coordination organization.

Susan E Palsbo1, Pei-Shu Ho.   

Abstract

Disability care coordination organizations (DCCOs) arrange comprehensive, disability-competent social and medical services for people with disabilities. This study used consumer ratings of access and quality to measure outcomes in one of the first operational DCCOs over a three-year period. Working-age Medicaid adults with physical disabilities reported statistically significant improvements in service coordination, patient education, system-wide disability competency, comprehensive assessment, health visit support, and self-direction of care. Global quality ratings showed statistically significant and sustained improvement over two years, with the percentage of people rating the health system as excellent rising from 7% before enrollment to 44% in the DCCO. The percentage of people rating primary care physicians as excellent rose from 18% before enrollment to 38% in the DCCO. Over time, enrollees became more knowledgeable about the need for preventive health care services, were more likely to receive needed care and medical equipment, and reduced their need for rehabilitation therapies. Disability care coordination organizations can reduce disparities and improve access to care for this vulnerable population.

Entities:  

Mesh:

Year:  2007        PMID: 17982213     DOI: 10.1353/hpu.2007.0104

Source DB:  PubMed          Journal:  J Health Care Poor Underserved        ISSN: 1049-2089


  2 in total

1.  Continuity in provider and site of care and preventive services receipt in an adult Medicaid population with physical disabilities.

Authors:  Susan M Allen; Susan Wieland; Jane Griffin; Pedro Gozalo
Journal:  Disabil Health J       Date:  2009-10       Impact factor: 2.554

2.  Use of emergency departments among working age adults with disabilities: a problem of access and service needs.

Authors:  Elizabeth K Rasch; Stephen P Gulley; Leighton Chan
Journal:  Health Serv Res       Date:  2012-12-26       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.